Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Peerj
|
November 25, 2025
DHCR7: from sterol biosynthesis to oncogenic role in colorectal cancer
Chuan Zhou, Jia Wang, Han He, et al.
Biochemical Genetics
|
May 27, 2023
Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer
Yongli Hu, Yan Du, Zhisheng Qiu, et al.
Discover Oncology
|
February 13, 2025
Acetyltransferase NAT10 promotes gastric cancer progression by regulating the Wnt/β-catenin signaling pathway and enhances chemotherapy resistance
Yawen Chen, Jian Yang, Yadan Du, et al.
The Lancet. Oncology
|
May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
Jian Zhou, Li Bai, Jia Luo, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Peerj
|
November 25, 2025
DHCR7: from sterol biosynthesis to oncogenic role in colorectal cancer
Chuan Zhou, Jia Wang, Han He, et al.
Biochemical Genetics
|
May 27, 2023
Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer
Yongli Hu, Yan Du, Zhisheng Qiu, et al.
Discover Oncology
|
February 13, 2025
Acetyltransferase NAT10 promotes gastric cancer progression by regulating the Wnt/β-catenin signaling pathway and enhances chemotherapy resistance
Yawen Chen, Jian Yang, Yadan Du, et al.
The Lancet. Oncology
|
May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
Jian Zhou, Li Bai, Jia Luo, et al.
Page
of 8